We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
Cap. Flow
-$91.9M
Cap. Flow %
-15.04%
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643

Top Buys

Rank Stock Value
1
BBY icon
Best Buy
BBY
+$2.79M
2
BBWI icon
Bath & Body Works
BBWI
+$2.78M
3
AMD icon
Advanced Micro Devices
AMD
+$2.7M
4
NVDA icon
NVIDIA
NVDA
+$2.4M
5
XOM icon
ExxonMobil
XOM
+$2.28M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.42%
2 Technology 16.03%
3 Healthcare 14.17%
4 Industrials 13.91%
5 Financials 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWO
801
Two Harbors Investment
TWO
$1.27B
$271K 0.04%
+10,626
New +$252K
AMC icon
802
AMC Entertainment Holdings
AMC
$2.31B
$270K 0.04%
+12,753
New +$417K
KRNY icon
803
Kearny Financial
KRNY
$599M
$270K 0.04%
25,558
+1,654
+7% +$15.6K
NMFC icon
804
New Mountain Finance
NMFC
$732M
$270K 0.04%
+23,800
New +$256K
NTNX icon
805
Nutanix
NTNX
$16.9B
$269K 0.04%
+8,442
New +$229K
AVXL icon
806
Anavex Life Sciences
AVXL
$310M
$268K 0.04%
49,678
+20,194
+68% +$106K
DGII icon
807
Digi International
DGII
$3.1B
$268K 0.04%
+14,185
New +$243K
OHI icon
808
Omega Healthcare
OHI
$14.7B
$268K 0.04%
7,376
+485
+7% +$16.4K
RUHN
809
DELISTED
Ruhnn Holding Limited American Depositary Shares
RUHN
$268K 0.04%
91,641
-29,007
-24% -$78.1K
TXG icon
810
10x Genomics
TXG
$6.61B
$267K 0.04%
1,888
+238
+14% +$34.5K
CVM icon
811
CEL-SCI Corp
CVM
$30.1M
$265K 0.04%
+757
New +$299K
PRI icon
812
Primerica
PRI
$9.89B
$265K 0.04%
+1,980
New +$249K
A icon
813
Agilent Technologies
A
$41.2B
$264K 0.04%
+2,224
New +$246K
GCO icon
814
Genesco
GCO
$422M
$264K 0.04%
+8,760
New +$224K
PGEN icon
815
Precigen
PGEN
$2.59B
$264K 0.04%
25,896
-171,826
-87% -$1.11M
RGS icon
816
Regis Corp
RGS
$70.2M
$264K 0.04%
+1,435
New +$219K
LXU icon
817
LSB Industries
LXU
$693M
$263K 0.04%
100,693
+2,586
+3% +$4.7K
FLR icon
818
Fluor
FLR
$7.96B
$262K 0.04%
+16,401
New +$232K
LOCO icon
819
El Pollo Loco
LOCO
$462M
$262K 0.04%
+14,472
New +$243K
AMRC icon
820
Ameresco
AMRC
$1.36B
$261K 0.04%
+5,005
New +$216K
CIVI
821
DELISTED
Civitas Resources
CIVI
$260K 0.04%
+13,427
New +$282K
SWK icon
822
Stanley Black & Decker
SWK
$15.7B
$260K 0.04%
1,454
-1,078
-43% -$191K
PLAN
823
DELISTED
Anaplan, Inc.
PLAN
$260K 0.04%
3,619
-479
-12% -$31.1K
SRPT icon
824
Sarepta Therapeutics
SRPT
$1.77B
$259K 0.04%
1,520
-1,624
-52% -$241K
AIOT
825
PowerFleet Inc
AIOT
$592M
$259K 0.04%
+34,910
New +$234K

Similar funds

GSA Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.

  • GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
  • GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
  • GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
  • GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
  • GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
  • GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.